DD Support Board and Research Team

[BullNBear52]

In my case it wasn't a chemist. It was a study done by Optum Rx that produced a formulary of what they would approve. (please don't say it was my case since I explained it) But to expand so people will understand.
https://www.optumrx.com/content/dam/openenrollment/pdfs/ers/7-1-23-PDL.pdf

It's 192 pages long and have fun seeing how they can reduce costs for the employer.

My wife's insurer did not use a pharmacy benefit manager and the drugs were billed to the healthcare provider Anthem BCBS.

Health insurers for employers decided they didn't want to deal with all the drug claims so they hired companies like Optum and CVS to deal with scripts.

My son's company uses Optum Rx as their pharmacy benefit manager.

Now if you're paying attention CVS has been quite successful in the PBM business while Walgreens WBA missed the boat entirely. Understanding this you'll start to realize why Amazon wants to get into the game.

https://pharmacy.amazon.com/

But the Feds are starting to notice.

Federal Trade Commission to sue drug middlemen over prices of medications including insulin, source says
PUBLISHED WED, JUL 10 20244:10 PM EDTUPDATED WED, JUL 10 20246:08 PM EDT
thumbnail
Annika Kim Constantino

KEY POINTS
The Federal Trade Commission is planning to sue three large U.S. health companies over their practices as middlemen who negotiate prices for medications such as insulin, a person familiar with the matter told CNBC.
The suits are set to target the three biggest so-called pharmacy benefit managers, UnitedHealth Group’s Optum Rx, CVS Health’s Caremark and Cigna’s Express Scripts, which are all owned by or connected to health insurers.
The agency argues their tactics contribute to inflated drug prices.
https://www.cnbc.com/2024/07/10/ftc-to-sue-pbms-over-drug-prices-including-insulin.html?&qsearchterm=optum%20rx